Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.510
+0.150 (3.44%)
At close: Jan 21, 2025, 4:00 PM
4.500
-0.010 (-0.22%)
After-hours: Jan 21, 2025, 4:15 PM EST
Vanda Pharmaceuticals Employees
Vanda Pharmaceuticals had 203 employees as of December 31, 2023. The number of employees decreased by 87 or -30.00% compared to the previous year.
Employees
203
Change (1Y)
-87
Growth (1Y)
-30.00%
Revenue / Employee
$940,187
Profits / Employee
-$80,729
Market Cap
262.97M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
VNDA News
- 13 days ago - Vanda's Letter to FDA Commissioner Highlights Faulty Gastroparesis NDA Review - PRNewsWire
- 4 weeks ago - Vanda Pharmaceuticals: Net-Net Status Presents A Trading Opportunity - Seeking Alpha
- 4 weeks ago - Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VGT-1849A, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera - PRNewsWire
- 5 weeks ago - Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc. - Business Wire
- 2 months ago - Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences - PRNewsWire
- 2 months ago - Vanda Pharmaceuticals Inc. (VNDA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst - Benzinga